The interleukin IL-22 plays important pathogenic roles in the initiation and development of AD, in part through the induction of keratinocyte production of type 2 cytokines and activation of the gastrin-releasing peptide (GRP)/GRPR pathway (Lou et al., 2017). Here, GRP is linked to Alzheimer disease.